0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Approved COVID-19 Vaccines Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-33V11381
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Approved COVID 19 Vaccines Market Research Report 2022
BUY CHAPTERS

Global Approved COVID-19 Vaccines Market Research Report 2025

Code: QYRE-Auto-33V11381
Report
January 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Approved COVID-19 Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Approved COVID-19 Vaccines Market

Approved COVID-19 Vaccines Market

The global market for Approved COVID-19 Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Approved COVID-19 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Approved COVID-19 Vaccines.
The Approved COVID-19 Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Approved COVID-19 Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Approved COVID-19 Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Approved COVID-19 Vaccines Market Report

Report Metric Details
Report Name Approved COVID-19 Vaccines Market
CAGR 5%
Segment by Type
  • Component Viral Vaccines
  • Whole Virus Vaccines
Segment by Application
  • Adults
  • Children
  • Elderly
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson&Johnson, Heat Biologics, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Approved COVID-19 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Approved COVID-19 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Approved COVID-19 Vaccines Market report?

Ans: The main players in the Approved COVID-19 Vaccines Market are Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson&Johnson, Heat Biologics, Sanofi

What are the Application segmentation covered in the Approved COVID-19 Vaccines Market report?

Ans: The Applications covered in the Approved COVID-19 Vaccines Market report are Adults, Children, Elderly

What are the Type segmentation covered in the Approved COVID-19 Vaccines Market report?

Ans: The Types covered in the Approved COVID-19 Vaccines Market report are Component Viral Vaccines, Whole Virus Vaccines

1 Approved COVID-19 Vaccines Market Overview
1.1 Product Definition
1.2 Approved COVID-19 Vaccines by Type
1.2.1 Global Approved COVID-19 Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Component Viral Vaccines
1.2.3 Whole Virus Vaccines
1.3 Approved COVID-19 Vaccines by Application
1.3.1 Global Approved COVID-19 Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Approved COVID-19 Vaccines Market Size Estimates and Forecasts
1.4.1 Global Approved COVID-19 Vaccines Revenue 2020-2031
1.4.2 Global Approved COVID-19 Vaccines Sales 2020-2031
1.4.3 Global Approved COVID-19 Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Approved COVID-19 Vaccines Market Competition by Manufacturers
2.1 Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Approved COVID-19 Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Approved COVID-19 Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Approved COVID-19 Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Approved COVID-19 Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Approved COVID-19 Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Approved COVID-19 Vaccines, Date of Enter into This Industry
2.8 Global Approved COVID-19 Vaccines Market Competitive Situation and Trends
2.8.1 Global Approved COVID-19 Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Approved COVID-19 Vaccines Players Market Share by Revenue
2.8.3 Global Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Approved COVID-19 Vaccines Market Scenario by Region
3.1 Global Approved COVID-19 Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Approved COVID-19 Vaccines Sales by Region: 2020-2031
3.2.1 Global Approved COVID-19 Vaccines Sales by Region: 2020-2025
3.2.2 Global Approved COVID-19 Vaccines Sales by Region: 2026-2031
3.3 Global Approved COVID-19 Vaccines Revenue by Region: 2020-2031
3.3.1 Global Approved COVID-19 Vaccines Revenue by Region: 2020-2025
3.3.2 Global Approved COVID-19 Vaccines Revenue by Region: 2026-2031
3.4 North America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.4.1 North America Approved COVID-19 Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Approved COVID-19 Vaccines Sales by Country (2020-2031)
3.4.3 North America Approved COVID-19 Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Approved COVID-19 Vaccines Market Facts & Figures by Country
3.5.1 Europe Approved COVID-19 Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Approved COVID-19 Vaccines Sales by Country (2020-2031)
3.5.3 Europe Approved COVID-19 Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Approved COVID-19 Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Approved COVID-19 Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Approved COVID-19 Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Approved COVID-19 Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.7.1 Latin America Approved COVID-19 Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Approved COVID-19 Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Approved COVID-19 Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Approved COVID-19 Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Approved COVID-19 Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Approved COVID-19 Vaccines Sales by Type (2020-2031)
4.1.1 Global Approved COVID-19 Vaccines Sales by Type (2020-2025)
4.1.2 Global Approved COVID-19 Vaccines Sales by Type (2026-2031)
4.1.3 Global Approved COVID-19 Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Approved COVID-19 Vaccines Revenue by Type (2020-2031)
4.2.1 Global Approved COVID-19 Vaccines Revenue by Type (2020-2025)
4.2.2 Global Approved COVID-19 Vaccines Revenue by Type (2026-2031)
4.2.3 Global Approved COVID-19 Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Approved COVID-19 Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Approved COVID-19 Vaccines Sales by Application (2020-2031)
5.1.1 Global Approved COVID-19 Vaccines Sales by Application (2020-2025)
5.1.2 Global Approved COVID-19 Vaccines Sales by Application (2026-2031)
5.1.3 Global Approved COVID-19 Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Approved COVID-19 Vaccines Revenue by Application (2020-2031)
5.2.1 Global Approved COVID-19 Vaccines Revenue by Application (2020-2025)
5.2.2 Global Approved COVID-19 Vaccines Revenue by Application (2026-2031)
5.2.3 Global Approved COVID-19 Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Approved COVID-19 Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Company Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Moderna Approved COVID-19 Vaccines Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Company Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CanSino Biologicals Approved COVID-19 Vaccines Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Company Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Company Information
6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolio
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Company Information
6.5.2 GlaxoSmithKine Description and Business Overview
6.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolio
6.5.5 GlaxoSmithKine Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Approved COVID-19 Vaccines Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson&Johnson
6.7.1 Johnson&Johnson Company Information
6.7.2 Johnson&Johnson Description and Business Overview
6.7.3 Johnson&Johnson Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Johnson&Johnson Approved COVID-19 Vaccines Product Portfolio
6.7.5 Johnson&Johnson Recent Developments/Updates
6.8 Heat Biologics
6.8.1 Heat Biologics Company Information
6.8.2 Heat Biologics Description and Business Overview
6.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Heat Biologics Approved COVID-19 Vaccines Product Portfolio
6.8.5 Heat Biologics Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Approved COVID-19 Vaccines Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Approved COVID-19 Vaccines Industry Chain Analysis
7.2 Approved COVID-19 Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Approved COVID-19 Vaccines Production Mode & Process Analysis
7.4 Approved COVID-19 Vaccines Sales and Marketing
7.4.1 Approved COVID-19 Vaccines Sales Channels
7.4.2 Approved COVID-19 Vaccines Distributors
7.5 Approved COVID-19 Vaccines Customer Analysis
8 Approved COVID-19 Vaccines Market Dynamics
8.1 Approved COVID-19 Vaccines Industry Trends
8.2 Approved COVID-19 Vaccines Market Drivers
8.3 Approved COVID-19 Vaccines Market Challenges
8.4 Approved COVID-19 Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Approved COVID-19 Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Approved COVID-19 Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Approved COVID-19 Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Approved COVID-19 Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Approved COVID-19 Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Approved COVID-19 Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Approved COVID-19 Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Approved COVID-19 Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Approved COVID-19 Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Approved COVID-19 Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Approved COVID-19 Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Approved COVID-19 Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Approved COVID-19 Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Approved COVID-19 Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Approved COVID-19 Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Approved COVID-19 Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Approved COVID-19 Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Approved COVID-19 Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Approved COVID-19 Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Approved COVID-19 Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Approved COVID-19 Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Approved COVID-19 Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Approved COVID-19 Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Approved COVID-19 Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Approved COVID-19 Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Approved COVID-19 Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Approved COVID-19 Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Approved COVID-19 Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Approved COVID-19 Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Approved COVID-19 Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Approved COVID-19 Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Approved COVID-19 Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Approved COVID-19 Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Approved COVID-19 Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Approved COVID-19 Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Approved COVID-19 Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Approved COVID-19 Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Approved COVID-19 Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Approved COVID-19 Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Approved COVID-19 Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Approved COVID-19 Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Approved COVID-19 Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Approved COVID-19 Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Approved COVID-19 Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Approved COVID-19 Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2026-2031)
 Table 70. Moderna Company Information
 Table 71. Moderna Description and Business Overview
 Table 72. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Moderna Approved COVID-19 Vaccines Product
 Table 74. Moderna Recent Developments/Updates
 Table 75. CanSino Biologicals Company Information
 Table 76. CanSino Biologicals Description and Business Overview
 Table 77. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CanSino Biologicals Approved COVID-19 Vaccines Product
 Table 79. CanSino Biologicals Recent Developments/Updates
 Table 80. Inovio Pharmaceuticals Company Information
 Table 81. Inovio Pharmaceuticals Description and Business Overview
 Table 82. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product
 Table 84. Inovio Pharmaceuticals Recent Developments/Updates
 Table 85. Shenzhen Geno-Immune Medical Institute Company Information
 Table 86. Shenzhen Geno-Immune Medical Institute Description and Business Overview
 Table 87. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product
 Table 89. Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
 Table 90. GlaxoSmithKine Company Information
 Table 91. GlaxoSmithKine Description and Business Overview
 Table 92. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKine Approved COVID-19 Vaccines Product
 Table 94. GlaxoSmithKine Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Approved COVID-19 Vaccines Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Johnson&Johnson Company Information
 Table 101. Johnson&Johnson Description and Business Overview
 Table 102. Johnson&Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Johnson&Johnson Approved COVID-19 Vaccines Product
 Table 104. Johnson&Johnson Recent Developments/Updates
 Table 105. Heat Biologics Company Information
 Table 106. Heat Biologics Description and Business Overview
 Table 107. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Heat Biologics Approved COVID-19 Vaccines Product
 Table 109. Heat Biologics Recent Developments/Updates
 Table 110. Sanofi Company Information
 Table 111. Sanofi Description and Business Overview
 Table 112. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sanofi Approved COVID-19 Vaccines Product
 Table 114. Sanofi Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Approved COVID-19 Vaccines Distributors List
 Table 118. Approved COVID-19 Vaccines Customers List
 Table 119. Approved COVID-19 Vaccines Market Trends
 Table 120. Approved COVID-19 Vaccines Market Drivers
 Table 121. Approved COVID-19 Vaccines Market Challenges
 Table 122. Approved COVID-19 Vaccines Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Approved COVID-19 Vaccines
 Figure 2. Global Approved COVID-19 Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Approved COVID-19 Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Component Viral Vaccines Product Picture
 Figure 5. Whole Virus Vaccines Product Picture
 Figure 6. Global Approved COVID-19 Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Approved COVID-19 Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Adults
 Figure 9. Children
 Figure 10. Elderly
 Figure 11. Global Approved COVID-19 Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Approved COVID-19 Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Approved COVID-19 Vaccines Sales (2020-2031) & (K Units)
 Figure 14. Global Approved COVID-19 Vaccines Average Price (US$/Unit) & (2020-2031)
 Figure 15. Approved COVID-19 Vaccines Report Years Considered
 Figure 16. Approved COVID-19 Vaccines Sales Share by Manufacturers in 2024
 Figure 17. Global Approved COVID-19 Vaccines Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Approved COVID-19 Vaccines Players: Market Share by Revenue in Approved COVID-19 Vaccines in 2024
 Figure 19. Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Approved COVID-19 Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Approved COVID-19 Vaccines Sales Market Share by Country (2020-2031)
 Figure 22. North America Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2031)
 Figure 23. United States Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Approved COVID-19 Vaccines Sales Market Share by Country (2020-2031)
 Figure 26. Europe Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Approved COVID-19 Vaccines Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Approved COVID-19 Vaccines Revenue Market Share by Region (2020-2031)
 Figure 34. China Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Approved COVID-19 Vaccines Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Approved COVID-19 Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Approved COVID-19 Vaccines by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Approved COVID-19 Vaccines by Type (2020-2031)
 Figure 56. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Approved COVID-19 Vaccines by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Approved COVID-19 Vaccines by Application (2020-2031)
 Figure 59. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2020-2031)
 Figure 60. Approved COVID-19 Vaccines Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS